GalNAc-modified FeS nanoparticles for specific chemodynamic and gas therapy against orthotopic hepatocellular carcinoma†

Abstract

GalNAc-modified ferrous sulfide nanoparticles have been developed to conduct chemodynamic and gas therapy for fighting against orthotopic hepatocellular carcinoma. This nanomedicine owns good liver targeting ability, which takes full advantage of the tumor microenvironment to ensure the therapy effect and improve the safety.